MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of prefer...
    • Depreciation and amortization
    • Mark-to-market adjustment of sto...
    • Others
Negative Cash Flow Breakdown
    • Noncash reduction of prior perio...
    • Claims payable
    • Health plan settlements payable
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
15,651
3,040
-165,714
-69,461
Noncash reduction of prior period medical expense
-56,000
-
-
-
Depreciation and amortization
21,044
21,074
20,995
21,033
Mark-to-market adjustment of stock warrants and purchased put option
16,366
-330
-5,066
2,540
Paid in-kind interest expense
3,911
10,799
9,905
19,813
Premium deficiency reserve
-8,659
-4,715
55,414
-23,736
Amortization of original issue discount and debt issuance costs
600
2,803
2,173
10,981
Impairment of assets held for sale
-
-
0
-
Equity-based compensation
866
1,051
1,099
1,211
Gain on write off of contingent consideration
-
-
0
0
Provision for bad debts
-
-
2,996
-
Deferred income taxes
0
478
2,868
-
Loss on asset sale and disposal
-127
-
178
-340
Health plan receivable
-5,263
32,436
10,565
-11,439
Clinic fees, insurance, and other receivable
294
5,681
2,506
-3,834
Prepaid expenses and other current assets
8,472
715
32
-4,762
Other long-term assets
-5,512
473
-8,749
-2,190
Accounts payable, accrued expenses, and other current liabilities
-4,017
420
3,322
1,586
Accrued payroll
-352
823
601
187
Health plan settlements payable
-22,597
-21,585
16,350
11,609
Claims payable
-30,822
-1,892
34,126
-2,373
Accrued interest
-
0
158
-12,653
Other long-term liabilities
-
-
0
-
Operating lease liability
-41
-128
-422
1,286
Net cash used in operating activities
-61,914
-27,467
-25,727
-15,412
Purchases of property and equipment
-
-
-198
119
Proceeds from asset sale
-
-
0
0
Other, net
208
43
-
-
Net cash provided by (used in) investing activities
-208
-43
198
-119
Proceeds from issuance of preferred stock, net of issuance costs
42,674
-
-
-
Proceeds from long-term debt, net of original issue discount
0
27,000
13,000
15,000
Net cash provided by financing activities
15,961
-
-
-
Proceeds from short-term debt
0
1,044
0
0
Repayment of short-term and long-term debt
417
209
114
341
Payment of debt issuance costs
0
30
12
-7
Proceeds from liability-classified warrants and private placement offering, net of offering costs paid
-
-
0
0
Proceeds from at-the-market sales, net of offering costs paid
-
-
0
0
Deferred offering costs paid
-
-
0
0
Payment of tax withholdings upon settlement of restricted stock unit awards
4
-
0
0
Net cash provided by financing activities
58,214
27,805
12,874
14,666
Net change in cash and restricted cash
-3,908
295
-12,655
-865
Cash and restricted cash, beginning of period
26,102
25,807
38,462
44,102
Cash and restricted cash, end of period
22,194
-
-
-
Cash
21,272
-
-
-
Restricted cash
922
-
-
-
Total cash and restricted cash
22,194
26,102
25,807
38,462
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofpreferred stock, net of...$42,674K Net cash provided byfinancing activities$15,961K (-64.75%↓ Y/Y)Net cash provided byfinancing activities$58,214K (28.58%↑ Y/Y)Canceled cashflow$421K Net change in cashand restricted cash-$3,908K (18.16%↑ Y/Y)Canceled cashflow$58,214K Depreciation andamortization$21,044K (-50.06%↓ Y/Y)Mark-to-market adjustment ofstock warrants and...$16,366K (407.40%↑ Y/Y)Net income (loss)$15,651K (117.80%↑ Y/Y)Other long-termassets-$5,512K (-138.11%↓ Y/Y)Health plan receivable-$5,263K (81.07%↑ Y/Y)Paid in-kindinterest expense$3,911K Equity-based compensation$866K (-73.52%↓ Y/Y)Amortization of originalissue discount and...$600K (49.25%↑ Y/Y)Loss on asset sale anddisposal-$127K Repayment of short-termand long-term debt$417K (-38.86%↓ Y/Y)Payment of taxwithholdings upon settlement...$4K Net cash used inoperating activities-$61,914K (-23.58%↓ Y/Y)Canceled cashflow$69,340K Net cash provided by(used in) investing...-$208K (-516.00%↓ Y/Y)Noncash reduction ofprior period medical...-$56,000K Claims payable-$30,822K (-3351.27%↓ Y/Y)Health plansettlements payable-$22,597K (-65.01%↓ Y/Y)Premium deficiencyreserve-$8,659K (33.03%↑ Y/Y)Prepaid expenses andother current assets$8,472K (384.95%↑ Y/Y)Accounts payable,accrued expenses, and...-$4,017K (-164.79%↓ Y/Y)Accrued payroll-$352K (77.44%↑ Y/Y)Clinic fees,insurance, and other...$294K (-91.89%↓ Y/Y)Operating lease liability-$41K (81.61%↑ Y/Y)Other, net$208K

P3 Health Partners Inc. (PIIIW)

P3 Health Partners Inc. (PIIIW)